
Glycorex Transplantation Investor Relations Material
Latest events

Q1 2025
23 May, 2025

Q4 2024
27 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Glycorex Transplantation
Access all reports
Glycorex Transplantation is a Swedish biotechnology company that develops and markets medical devices for organ and blood compatibility. The company’s core technology removes specific antibodies from blood, enabling safer organ transplants and transfusions. It serves hospitals and healthcare providers globally. Glycorex Transplantation is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
GTAB
Country
🇸🇪 Sweden